Back to Research Hub
MeiraGTx Holdings plc
MGTX
$13.71-0.10 (-0.76%)
MeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals afflicted by serious illnesses.
StreetsValue research for MeiraGTx Holdings plc (MGTX)
Members get the full report for MeiraGTx Holdings plc: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.